1. The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk

   • Stephen Pratt
   • Vincent J. Thompson
   • Elisabeth Sörstadius

   Original Research Article 20 August 2012 Pages: 281 - 288

   

2. An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension

   • Joel M. Neutel
   • Dean J. Kereiakes
   • The BENIFICIARY Investigators

   Original Research Article 20 August 2012 Pages: 289 - 303

   

3. A 50-Week Extension Study on the Safety and Efficacy of Colesevelam in Adults with Primary Hypercholesterolemia

   • Michael H. Davidson
   • Joanne M. Donovan
   • Michael R. Jones

   Original Research Article 20 August 2012 Pages: 305 - 314

   

4. The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension

   • Steven G. Chrysant

   Review Article 20 August 2012 Pages: 315 - 320

   

5. Cardiovascular Risk-Benefit Profile of Sibutramine

   • André J. Scheen

   Review Article 20 August 2012 Pages: 321 - 334

   

6. Candesartan Cilexetil

   • Sheridan M. Hoy
   • Gillian M. Keating

   Adis Drug Profile 20 August 2012 Pages: 335 - 342

7. Riferminogene Pecaplasmide

   Adis R&D Profile 20 August 2012 Pages: 343 - 346